Astrazeneca has launched its global strategic research and development center in Beijing
According to Astrazeneca, it has officially launched a new global strategic research and development center in Beijing. This research center is Astrazeneca's sixth globally and its second strategic research and development center in China, and it is also a core project of Astrazeneca's $2.5 billion investment plan in China. It is reported that the Global R&D Beijing Strategic Center has an artificial intelligence and data science center, aiming to accelerate the translation of early drug research results into clinical development
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments